We are live on ! Find out more
SRPT icon

Sarepta Therapeutics
SRPT

328 hedge funds and large institutions have $5.71B invested in Sarepta Therapeutics in 2022 Q1 according to their latest regulatory filings, with 53 funds opening new positions, 94 increasing their positions, 122 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more call options, than puts

Call options by funds: $135M | Put options by funds: $82.1M

1.21% more ownership

Funds ownership: 82.61% → 83.82% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

4% less funds holding

Funds holding: 343 → 328 (-15)

12% less capital invested

Capital invested by funds: $6.48B → $5.71B (-$771M)

16% less first-time investments, than exits

New positions opened: 53 | Existing positions closed: 63

23% less repeat investments, than reductions

Existing positions increased: 94 | Existing positions reduced: 122

Holders
328
Holders Change
-15
Holders Change %
-4.37%
% of All Funds
5.17%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
53
Increased
94
Reduced
122
Closed
63
Calls
$135M
Puts
$82.1M
Net Calls
+$52.8M
Net Calls Change
-$34.9M

Top Buyers

1
EC
EcoR1 Capital
California
+$158M
2
American Century Companies
American Century Companies
Missouri
+$62.7M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$51.6M
4
CCM
Camber Capital Management
Massachusetts
+$42.1M
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$35.3M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$103M
2
RI
RTW Investments
New York
-$52.4M
3
Marshall Wace
Marshall Wace
United Kingdom
-$45.4M
4
Sands Capital Management
Sands Capital Management
Virginia
-$44.5M
5
Victory Capital Management
Victory Capital Management
Texas
-$44.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$650M +$312K +4,074 +0%
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$583M +$16.3M +212,720 +3%
BlackRock
3
BlackRock
New York
$433M +$20M +261,725 +5%
Sands Capital Management
4
Sands Capital Management
Virginia
$374M -$44.5M -581,676 -11%
ACA
5
Avoro Capital Advisors
New York
$245M +$766K +10,000 +0.3%
Wellington Management Group
6
Wellington Management Group
Massachusetts
$209M +$51.6M +673,725 +34%
EC
7
EcoR1 Capital
California
$162M +$158M +2,069,634 New
State Street
8
State Street
Massachusetts
$161M +$14.9M +194,320 +10%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$154M -$2.52M -32,912 -2%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$121M -$103M -1,347,437 -47%
Point72 Asset Management
11
Point72 Asset Management
Connecticut
$113M +$22.7M +296,002 +26%
CCM
12
Camber Capital Management
Massachusetts
$107M +$42.1M +550,000 +67%
Alkeon Capital Management
13
Alkeon Capital Management
New York
$91.9M +$6.19M +80,796 +7%
BG
14
Bellevue Group
Switzerland
$89.9M +$24.8M +324,418 +39%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$89.7M +$1.27M +16,614 +1%
T. Rowe Price Associates
16
T. Rowe Price Associates
Maryland
$88.8M +$30.7M +401,247 +55%
JP Morgan Chase
17
JP Morgan Chase
New York
$85.2M +$3.22M +42,043 +4%
Adage Capital Partners
18
Adage Capital Partners
Massachusetts
$79.3M +$28M +365,000 +56%
FCM
19
Farallon Capital Management
California
$77.5M +$11.7M +152,966 +18%
Ameriprise
20
Ameriprise
Minnesota
$76.8M -$8.74M -114,169 -10%
Goldman Sachs
21
Goldman Sachs
New York
$72.2M -$6.29M -82,149 -8%
First Trust Advisors
22
First Trust Advisors
Illinois
$67.2M -$3.01M -39,308 -4%
American Century Companies
23
American Century Companies
Missouri
$64M +$62.7M +819,073 New
CC
24
Casdin Capital
New York
$62.5M -$42.1M -550,000 -41%
EAM
25
Erste Asset Management
Austria
$60.9M -$6.28M -82,000 -10%
1
2 3 4 5

SRPT Hedge Fund Activity: Q1 2022 in Review

328 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Sarepta Therapeutics (SRPT) for Q1 2022, worth a combined $5.71B — down 12% from $6.48B a quarter earlier.

Sellers outnumbered buyers: 63 funds closed out of SRPT and 53 opened new positions — a net loss of 10 holders — while 122 trimmed existing stakes and 94 added.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $158M. The largest seller was Fidelity Investments, cutting an estimated $103M.

  • 328 institutional investors held Sarepta Therapeutics (SRPT) as of Q1 2022, down from 343 in Q4 2021.
  • Funds reported $5.71B of Sarepta Therapeutics stock for Q1 2022, down 12% quarter-over-quarter.
  • 53 funds opened new Sarepta Therapeutics positions in Q1 2022 and 63 closed out, a net change of -10 holders.
  • The largest Sarepta Therapeutics buyer in Q1 2022 was EcoR1 Capital, an estimated $158M added.
  • The largest Sarepta Therapeutics seller in Q1 2022 was Fidelity Investments, an estimated $103M sold.

Based on aggregated 13F filings for Q1 2022.